Image guided high intensity focused ultrasound treatment of nerves

• US 8,206,299 B2
• Filed: 09/21/2010
• Issued: 06/26/2012
• Est. Priority Date: 12/16/2003
• Status: Active Grant

• Current Assignee: University of Washington
• Original Assignee: University of Washington
• Inventors: Foley, Jessica L., Vaezy, Shahram, Little, James W.
• Primary Examiner(s): Rozanski, Michael
• Application Number:
  US12/887,211
• Publication Number:
  US 20110009734A1
• Time in Patent Office: 644 Days
• Field of Search: 601/2, 600/411, 600/437, 600/439
• US Class Current: 600/439
• CPC Class Codes: A61B 2017/320069 for ablating tissue
• CPC Class Codes: A61B 2090/378 using ultrasound
• CPC Class Codes: A61B 5/0035 adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
• CPC Class Codes: A61B 8/0808 for diagnosis of the brain
• CPC Class Codes: A61B 8/13 Tomography A61B8/10, A61B8/12 take precedence; tomography for radiation diagnosis A61B6/02
• CPC Class Codes: A61B 8/4209 by using holders, e.g. positioning frames
• CPC Class Codes: A61B 8/4254 using sensors mounted on the probe
• CPC Class Codes: A61B 8/4272 involving the acoustic interface between the transducer and the tissue
• CPC Class Codes: A61B 8/4281 characterised by sound-transmitting media or devices for coupling the transducer to the tissue
• CPC Class Codes: A61N 7/02 Localised ultrasound hyperthermia hyperthermia in general A61F7/00

Abstract

A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.

Claims

1. A method for using a high intensity focused ultrasound (HIFU) probe to provide therapy to a peripheral nerve at a treatment site in a patient, the method comprising the steps of:

(a) positioning, external to the body, (i) a HIFU therapy probe having a focal point, and (ii) an ultrasound imaging device in proximity to the peripheral nerve;

(b) creating an image of the treatment site with the imaging device by generating a sequence of ultrasonic imaging pulses that propagate to the treatment site;

(c) verifying the position of the focal point of the HIFU probe relative to the treatment site in the image created in step (b) using imaging ultrasound;

(d) after said verifying, administering a dose of HIFU to the peripheral nerve to achieve a therapeutic effect; and

(e) during said administering, synchronizing and pulsing an HIFU wave produced by the HIFU probe with respect to the imaging pulses such that the HIFU probe'"'"'s focal point can be viewed in the image during treatment.

2. The method of claim 1, wherein the imaging ultrasound comprises three dimensional (3D) ultrasound.

3. The method of claim 1, wherein the imaging ultrasound comprises two dimensional (2D) ultrasound.

4. The method of claim 1, wherein the step of verifying the position of the focal point of the HIFU probe relative to the treatment site comprises the steps of:

(a) energizing the HIFU probe using a power level sufficient to change an echogenicity of tissue proximate the focal point, but insufficient to achieve a therapeutic effect; and

(b) using the imaging ultrasound to detect the change in echogenicity, thereby verifying the position of the focal point.

5. The method of claim 1, further comprising the step of delivering a blood soluble agent to the patient prior to administering the dose of HIFU.

6. The method of claim 5, wherein the blood soluble agent is an anesthetic.

7. The method of claim 1, wherein the step of administering the dose of HIFU to the peripheral nerve comprises the step of using a HIFU power output level ranging from about 50 to about 2000 W/cm².

8. The method of claim 1, wherein the step of administering the dose of HIFU to the peripheral nerve comprises the step of using a HIFU power output level ranging from about 1480 to about 1850 W/cm².

9. The method of claim 1, wherein step (c) includes (i) generating a synchronization pulse that establishes a timing reference point for generating the sequence of ultrasonic imaging pulses in step (b), and (ii) pulsing the HIFU probe after a given time delay from the synchronization pulse sufficient to shift noise from the HIFU pulse away from the treatment site.